APA (7th ed.) Citation

Fan, Z., Li, D., Yan, S., Zhao, X., Yin, L., Xu, W., . . . Ren, S. (2025). NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): Study protocol of a multicenter, open-label, randomised controlled trial. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-024-13201-w

Chicago Style (17th ed.) Citation

Fan, Zhiguo, et al. "NEoAdjuvant Radiohormonal Therapy Versus Standard of Care for Oligometastatic Prostate Cancer (NEAR-TOP): Study Protocol of a Multicenter, Open-label, Randomised Controlled Trial." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-024-13201-w.

MLA (9th ed.) Citation

Fan, Zhiguo, et al. "NEoAdjuvant Radiohormonal Therapy Versus Standard of Care for Oligometastatic Prostate Cancer (NEAR-TOP): Study Protocol of a Multicenter, Open-label, Randomised Controlled Trial." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-024-13201-w.